VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Diabetic nephropathy (DN) is considered the primary causes of end-stage renal disease (ESRD) and is related to abnormal glycolipid metabolism, hemodynamic abnormalities, oxidative stress and chronic inflammation. Antagonism of vascular endothelial growth factor B (VEGF-B) could efficiently ameliorat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharm Sin B
Main Authors: Shen, Yilan, Chen, Wei, Han, Lei, Bian, Qi, Fan, Jiajun, Cao, Zhonglian, Jin, Xin, Ding, Tao, Xian, Zongshu, Guo, Zhiyong, Zhang, Wei, Ju, Dianwen, Mei, Xiaobin
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7838033/
https://ncbi.nlm.nih.gov/pubmed/33532185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.07.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados